FOXO1-IN-3结构式
|
常用名 | FOXO1-IN-3 | 英文名 | FOXO1-IN-3 |
|---|---|---|---|---|
| CAS号 | 2451093-95-9 | 分子量 | 401.46 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C22H23N7O | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
FOXO1-IN-3用途FOXO1-IN-3是一种高选择性和口服活性的FOXO1抑制剂。FOXO1-IN-3降低小鼠肝脏葡萄糖的产生。FOXO1-IN-3改善db/db小鼠的胰岛素敏感性和葡萄糖控制,而不会导致体重增加[1]。 |
| 英文名 | FOXO1-IN-3 |
|---|
| 描述 | FOXO1-IN-3是一种高选择性和口服活性的FOXO1抑制剂。FOXO1-IN-3降低小鼠肝脏葡萄糖的产生。FOXO1-IN-3改善db/db小鼠的胰岛素敏感性和葡萄糖控制,而不会导致体重增加[1]。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
FOXO1[1] |
| 体外研究 | FOXO1-IN-3(化合物10)(10μM,6小时) 抑制正常小鼠原代肝细胞中 cAMP/地塞米松(HY-14648)诱导的 G6pc和 Pck1mRNA表达[1] RT-PCRsup>[1]细胞系:从正常小鼠分离的原代肝细胞浓度:10μM孵育时间:6h结果:抑制的cAMP/地塞米松(HY-14648)诱导G6pc和Pck1mRNA表达,并且不影响Foxo1水平。 |
| 参考文献 |
| 分子式 | C22H23N7O |
|---|---|
| 分子量 | 401.46 |
|
实验名称:Metabolic stability in human hepatocytes assessed as compound remaining at 0.3 uM mea...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5393546
|
|
实验名称:Metabolic stability in human hepatocytes assessed as intrinsic clearance measured per...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5393545
|
|
实验名称:Metabolic stability in CD-1 mouse liver microsomes assessed as compound remaining at ...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5393544
|
|
实验名称:Metabolic stability in CD-1 mouse liver microsomes assessed as intrinsic clearance at...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5393543
|
|
实验名称:Inhibition of human FOXO1 expressed in HEK293 cells at 1 nM to 50 uM by Dual-Glo luci...
来源:ChEMBL
靶标:Forkhead box protein O1
External Id:CHEMBL5393542
|
|
实验名称:Inhibition of human FOXO1 expressed in HEK293 cells by Dual-Glo luciferase assay
来源:ChEMBL
靶标:Forkhead box protein O1
External Id:CHEMBL5393541
|